EAU 2014 - Poster: Nadir testosterone on ADT predicts for time to castrate resistant progression: A secondary analysis of the PR-7 intermittent vs continuous ADT trial

STOCKHOLM, SWEDEN (UroToday.com) - Presented by L. Klotz, C. O’Callaghan, D. Dearnaley, T. Higano, A. Horwitz, S. Malone , Y. Liu, L. Goldenberg, M. Gospodarowicz, and J. Crook at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Klotz-poster EAU thumb

Sunnybrook Health Sciences Centre, Toronto, Canada

Click HERE to read an exclusive report by a UroToday medical writer 

Click HERE to listen to Laurence Klotz, MD discuss the key points from this poster